financetom
Business
financetom
/
Business
/
ConocoPhillips nears sale of Oklahoma assets to Stone Ridge Energy, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ConocoPhillips nears sale of Oklahoma assets to Stone Ridge Energy, sources say
Jul 22, 2025 3:09 PM

NEW YORK (Reuters) -U.S. oil and gas producer ConocoPhillips ( COP ) is in advanced talks to sell assets in Oklahoma to privately owned Stone Ridge Energy for around $1.3 billion, three people familiar with the matter told Reuters on Tuesday.

Oklahoma City-based Flywheel Energy, a private oil and gas company backed by Stone Ridge Energy, will operate the assets on its backer's behalf, one of the sources said.

The sources cautioned that no deal is guaranteed and talks could still end without an agreement. They also spoke on condition of anonymity to discuss private deliberations.

ConocoPhillips ( COP ) declined to comment. Stone Ridge Energy, the energy-focused arm of New York-based Stone Ridge Asset Management, did not immediately respond to a request for comment.

Flywheel, which also counts commodities trader Gunvor among its investors, did not immediately respond to requests for comment.

Reuters reported in April that ConocoPhillips ( COP ) had hired investment bank Moelis & Co to manage an auction of the assets, which are comprised of operations in the Anadarko basin inherited by the energy producer as part of its $22.5 billion takeover of Marathon Oil last year.

As part of the deal, Stone Ridge Energy will acquire 300,000 net acres (121,406 hectares) in the Anadarko shale formation, which produce about 39,000 barrels of oil equivalent per day, of which about half is natural gas.

If completed, the asset sale would help ConocoPhillips ( COP ) surpass a target to raise $2 billion from divestments. Conoco set that target after it took on about $5.4 billion of Marathon's debt as part of that acquisition.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Advance Auto Parts to Sell Worldpac to Carlyle for $1.5 Billion in Cash
Advance Auto Parts to Sell Worldpac to Carlyle for $1.5 Billion in Cash
Aug 23, 2024
06:39 AM EDT, 08/22/2024 (MT Newswires) -- Advance Auto Parts ( AAP ) said Thursday it has agreed to sell Worldpac Inc., its automotive parts wholesale distribution business, to funds managed by Carlyle Group ( CG ) for $1.5 billion in cash. The company expects net proceeds of about $1.2 billion after taxes and transaction fees. The deal, slated to...
Indian ed-tech giant Byju's insolvency case fans employees' fears
Indian ed-tech giant Byju's insolvency case fans employees' fears
Aug 23, 2024
* Firm was once valued at $22 bln in India * Fall seen as setback for employees, startup sector * Employees weigh legal options, protests * Lenders' dispute triggered insolvency case (Updates paragraph 8 with court hearing details) By Ashwin Manikandan, Arpan Chaturvedi and Munsif Vengattil BENGALURU/NEW DELHI, Aug 22 (Reuters) - The insolvency of Indian education technology company Byju's...
EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details
EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details
Aug 23, 2024
EHang Holdings Limited ( EH ) shares are trading higher after it reported second-quarter results. Revenue escalated 919.6% Y/Y to RMB102.0 million. In USD terms, revenue of $14.04 million beat the consensus of $12.58 million. Revenue benefitted from strong demand for the advanced EH216-S pilotless eVTOL vehicles. Gross profit surged 957.3% Y/Y to RMB63.7 million ($8.7 million), with a gross margin of 62.4%, up 2.2 percentage points Y/Y. Adjusted...
Biogen, Eisai's Mild Dementia Treatment Gets Marketing Authorization From UK Regulatory Authority
Biogen, Eisai's Mild Dementia Treatment Gets Marketing Authorization From UK Regulatory Authority
Aug 23, 2024
06:31 AM EDT, 08/22/2024 (MT Newswires) -- Biogen (BIIB) and Japan's Eisai Co. ( ESALF ) said early Thursday that their humanized amyloid-beta monoclonal antibody, lecanemab, received marketing authorization from the UK's regulatory authority. The company said lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in certain types of adult patients....
Copyright 2023-2026 - www.financetom.com All Rights Reserved